THEROSCA Trademark

Trademark Overview

On Tuesday, October 27, 2020, a trademark application was filed for THEROSCA with the United States Patent and Trademark Office. The USPTO has given the THEROSCA trademark a serial number of 90281698. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2024. This trademark is owned by Pfizer Inc.. The THEROSCA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, antivirals
therosca

General Information

Serial Number90281698
Word MarkTHEROSCA
Filing DateTuesday, October 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2021

Trademark Statements

Goods and ServicesPharmaceuticals, namely, antivirals
Pseudo MarkTHE ROSCA

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, October 30, 2020NEW APPLICATION ENTERED
Thursday, December 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 26, 2021ASSIGNED TO EXAMINER
Monday, March 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 1, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 3, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021SOU EXTENSION 1 FILED
Wednesday, November 3, 2021SOU EXTENSION 1 GRANTED
Monday, May 2, 2022SOU EXTENSION 2 GRANTED
Friday, November 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 2, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 2, 2022SOU EXTENSION 2 FILED
Wednesday, May 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 3, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2022SOU EXTENSION 3 FILED
Tuesday, October 4, 2022SOU EXTENSION 3 GRANTED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 15, 2023SOU EXTENSION 4 GRANTED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 4 FILED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023SOU EXTENSION 5 FILED
Wednesday, November 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Wednesday, November 8, 2023SOU EXTENSION 5 GRANTED

Related Keywords

therosca antivirals namely pharmaceuticals